USANA Health Sciences, Inc. (USNA)
NYSE: USNA · Real-Time Price · USD
18.83
-0.50 (-2.59%)
Mar 5, 2026, 1:01 PM EST - Market open
USANA Health Sciences Stock Forecast
Stock Price Forecast
There is currently no analyst price target forecast available for USANA Health Sciences.
Analyst Consensus: n/a
Analyst Ratings
There are currently no analyst ratings available for USANA Health Sciences.
Recommendation Trends
| Rating | Sep '24 | Oct '24 | Nov '24 | Dec '24 | Jan '25 | Feb '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 1 | 1 | 1 | 1 | 1 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 1 | 1 | 1 | 1 | 1 | 0 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| DA Davidson | DA Davidson | Hold Maintains $38 → $36 | Hold | Maintains | $38 → $36 | +91.18% | Feb 27, 2025 |
| DA Davidson | DA Davidson | Hold Maintains $35 → $38 | Hold | Maintains | $35 → $38 | +101.81% | Jan 2, 2025 |
| DA Davidson | DA Davidson | Hold Maintains $38 → $35 | Hold | Maintains | $38 → $35 | +85.87% | Oct 23, 2024 |
| DA Davidson | DA Davidson | Hold Maintains $46 → $38 | Hold | Maintains | $46 → $38 | +101.81% | Jul 25, 2024 |
| DA Davidson | DA Davidson | Hold Maintains $48 → $46 | Hold | Maintains | $48 → $46 | +144.29% | May 7, 2024 |
Financial Forecast
Revenue This Year
961.25M
from 925.26M
Increased by 3.89%
Revenue Next Year
1.02B
from 961.25M
Increased by 6.22%
EPS This Year
2.04
from 0.58
Increased by 252.15%
EPS Next Year
2.83
from 2.04
Increased by 38.50%
Revenue Forecast
| Revenue | 2026 | 2027 |
|---|---|---|
| High | 989.5M | 1.1B |
| Avg | 961.3M | 1.0B |
| Low | 923.6M | 981.1M |
Revenue Growth
| Revenue Growth | 2026 | 2027 |
|---|---|---|
| High | 6.9% | 9.3% |
| Avg | 3.9% | 6.2% |
| Low | -0.2% | 2.1% |
EPS Forecast
| EPS | 2026 | 2027 |
|---|---|---|
| High | 2.10 | 2.91 |
| Avg | 2.04 | 2.83 |
| Low | 1.96 | 2.71 |
EPS Growth
| EPS Growth | 2026 | 2027 |
|---|---|---|
| High | 262.5% | 42.6% |
| Avg | 252.1% | 38.5% |
| Low | 238.3% | 33.1% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.